Somewhat unexpectedly, this property was associated with a profound downregulation of autophagy-suppressing AKT/mTORC1 pathway in GO- or GNF-treated pheochromocytoma, lung carcinoma, and glioma cells [44,45,46]. This evidence concerns the gene AKT1 and central nervous system cancer.